Standard BioTools Inc. Common Stock — Quarterly Financial Statements (NASDAQ:LAB)

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Market Capitalization 429.93 M
Employee 818
Founded 1999
CEO N/A
Website www.standardbio.com
Headquarter Delaware, United States
FIGI BBG000S8WQB6
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

429.93 M Market capitalization

Price to earnings ratio

-4.19

Price to sales ratio

2.86

Dividends per share

—

Dividend yield %

—

Standard BioTools Inc

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.